Mechanisms of doxorubicin resistance of breast cancer MCF-7 cells mediated by exosomes
10.16438/j.0513-4870.2018-1024
- VernacularTitle:外泌体介导乳腺癌 MCF-7 细胞对多柔比星耐药性的机制
- Author:
Ru-yue ZHANG
1
;
Duo-lu LI
1
;
Zhe YANG
1
;
Jin-xiu GUO
1
;
Yu-bing ZHOU
1
Author Information
1. Department of Pharmacy, The First Affiliated Hospital, Zhengzhou University, Henan Key Laboratory for Precision Clinical Pharmacy, Zhengzhou 450052, China
- Publication Type:Research Article
- Keywords:
exosome;
breast cancer;
rug resistance;
oxorubicin;
multidrug resistance protein
- From:
Acta Pharmaceutica Sinica
2019;54(5):861-866
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to explore the roles of exosomes in doxorubicin-resistance in breast cancer cells. Using breast cancer parental cell line (MCF-7), doxorubicin-resistant cell line (MCF-7/ADR) and sensitive cell line co-cultured with doxorubicin-resistant supernatant (MCF-7/EXO) as models, the effects of doxorubicin on proliferation or apoptosis of MCF-7, MCF-7/EXO and MCF-7/ADR cells were detected by CCK8, and light or fluorescent microscopy. Exosomes in the supernatants of cell culture were extracted by ultracentrifugation, and the quantity of exosomes was determined by transmission electron microscopy, BCA and DiI labeling assay. Expression levels of exosome-specific biomarkers CD63 and Flotillin-1 were detected by Western blot. The uptake of MCF-7/ADR cell-derived exosomes by MCF-7 cells was observed by laser confocal microscopy. Western blot was used to detect the expression levels of multidrug resistance protein ATP-binding cassette subfamily B member 1 (ABCB1) in all three cell strains. Cell proliferation assays showed that IC50 of MCF-7/EXO cells to doxorubicin was 0.83 ± 0.09 μmol·L-1, which was significantly higher than 0.15 ± 0.05 μmol·L-1 (P<0.01) of MCF-7 cells, suggesting 5.5 times of increase in drug resistance. Apoptosis of MCF-7 cells was induced after doxorubicin treatment (P<0.001), but MCF-7/EXO cells were not significantly different (P>0.05). Exosome quantification and specific marker detection showed that MCF-7/EXO cells had significantly more exosomes than MCF-7 cells (P<0.05). PKH67 tracer markers indicated that MCF-7/ADR-derived exosomes could be taken up by MCF-7 cells. Western blot showed that the expression level of ABCB1 protein in MCF-7/EXO cells was significantly higher than that in MCF-7 cells. Taken together, these results indicate that exosomes of doxorubicin-resistant breast cancer cells can transmit drug resistance to sensitive cells, and the underlying mechanism may involve ABCB1 protein transport mediated by exosomes.
